Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015Anna Sureda, Peter Bader, Simone Cesaro et al.|Bone Marrow Transplantation|2015Cited by 337
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Peter A. van Veelen et al.|Journal of Clinical Investigation|2019Cited by 232
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsMohamad Mohty, Jakob Passweg, Helen Baldomero et al.|Bone Marrow Transplantation|2015Cited by 205
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantationJ. Alejandro Madrigal, Jakob Passweg, Helen Baldomero et al.|Bone Marrow Transplantation|2014Cited by 178
Hematopoietic SCT in Europe: data and trends in 2011J. Alejandro Madrigal, Jakob Passweg, Helen Baldomero et al.|Bone Marrow Transplantation|2013Cited by 132